Literature DB >> 14163985

SOME NARCOTIC ANTAGONISTS IN THE BENZOMORPHAN SERIES.

L S HARRIS, A K PIERSON.   

Abstract

Entities:  

Keywords:  ANALGESICS AND ANTIPYRETICS; AZOCINES; CATS; CYCLAZOCINE; EXPERIMENTAL LAB STUDY; HETEROCYCLIC COMPOUNDS; MEPERIDINE; MICE; MONKEYS; MORPHINE; NALORPHINE; NARCOTIC ANTAGONISTS; PENTAZOCINE; PHARMACOLOGY; PHENAZOCINE; RATS; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14163985

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  73 in total

1.  NARCOTIC ANTAGONISTS IN THE BENZOMORPHAN SERIES. RESPIRATORY, CARDIOVASCULAR AND BEHAVIORAL EFFECTS IN DOGS.

Authors:  L S HARRIS
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-07-20

2.  NEUROLEPTANALGESICS. 2. LABORATORY EVALUATION OF COMBINATION OF ANALGESICS AND NEUROLEPTICS WITH NITROUS OXIDE.

Authors:  A B DOBKIN; P K LEE; P H BYLES
Journal:  Can Anaesth Soc J       Date:  1965-01

3.  Opioid activity of spinally selective analogues of N-naphthoyl-β-naltrexamine in HEK-293 cells and mice.

Authors:  Morgan Le Naour; Mary M Lunzer; Mike D Powers; Philip S Portoghese
Journal:  J Med Chem       Date:  2012-01-05       Impact factor: 7.446

4.  Role of CD38, a cyclic ADP-ribosylcyclase, in morphine antinociception and tolerance.

Authors:  Lynn C Hull; Christopher Rabender; Bichoy H Gabra; Fan Zhang; Pin-Lan Li; William L Dewey
Journal:  J Pharmacol Exp Ther       Date:  2010-06-15       Impact factor: 4.030

5.  Increased sensitivity to rate-altering and discriminative stimulus effects of morphine following continuous exposure to naltrexone.

Authors:  A M Young; S R Mattox; M D Doty
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

6.  Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.

Authors:  Shao M Tham; James A Angus; Elizabeth M Tudor; Christine E Wright
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

7.  Sphingosine-1-phosphate receptors mediate neuromodulatory functions in the CNS.

Authors:  Laura J Sim-Selley; Paulette B Goforth; Mba U Mba; Timothy L Macdonald; Kevin R Lynch; Sheldon Milstien; Sarah Spiegel; Leslie S Satin; Sandra P Welch; Dana E Selley
Journal:  J Neurochem       Date:  2009-05-31       Impact factor: 5.372

8.  Region-dependent attenuation of mu opioid receptor-mediated G-protein activation in mouse CNS as a function of morphine tolerance.

Authors:  L J Sim-Selley; K L Scoggins; M P Cassidy; L A Smith; W L Dewey; F L Smith; D E Selley
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

9.  Comparison of analgesia by intravenous butorphanol and meperidine in patients with post-operative pain.

Authors:  F M Galloway; J Hrdlicka; M Losada; R J Noveck; F S Caruso
Journal:  Can Anaesth Soc J       Date:  1977-01

10.  The effect of protein kinase C and G protein-coupled receptor kinase inhibition on tolerance induced by mu-opioid agonists of different efficacy.

Authors:  L C Hull; J Llorente; B H Gabra; F L Smith; E Kelly; C Bailey; G Henderson; W L Dewey
Journal:  J Pharmacol Exp Ther       Date:  2009-12-14       Impact factor: 4.030
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.